These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4293412)

  • 1. Evaluation of Sabin live poliovirus vaccine in Japan. 3. Studies on the method of administration of Sabin vaccine for babies.
    Kono R
    Jpn J Med Sci Biol; 1967 Apr; 20(2):151-66. PubMed ID: 4293412
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
    Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
    Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Poliomyelitis vaccination, Sabin type, in 1-month-old and 3-month-old infants].
    Neves WE; Rodrigues MC; Kipnis J; Carvalho RP; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1968; 10(6):376-82. PubMed ID: 4303642
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).
    Tagaya I; Nakao C; Hara M; Yamadera S
    Bull World Health Organ; 1973 May; 48(5):547-54. PubMed ID: 4359681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Sabin live poliovirus vaccine in Japan. IV. Marker tests on poliovirus strains recovered from vaccinees and their contacts.
    Ogonuki H
    Jpn J Med Sci Biol; 1967 Apr; 20(2):167-73. PubMed ID: 4293413
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children.
    Jpn J Med Sci Biol; 1966 Dec; 19(6):277-91. PubMed ID: 4293159
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excretion rates after Sabin oral vaccination against poliomyelitis in Tyrol].
    Bauer P
    Arch Hyg Bakteriol; 1968 Dec; 152(5):410-4. PubMed ID: 4313799
    [No Abstract]   [Full Text] [Related]  

  • 9. Shedding of sabin poliovirus Type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine.
    Martinez CV; Old MO; Kwock DK; Khan SS; Garcia JJ; Chan CS; Webster R; Falkovitz-Halpern MS; Maldonado YA
    J Infect Dis; 2004 Jul; 190(2):409-16. PubMed ID: 15216480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of poliovirus-isolates in Japan, 2000.
    Yoneyama T; Sakae K; Baba J; Nakayama T; Chijiwa K; Kizoe K; Shimizu H; Iizuka S; Ishizaki T; Kondo R; Miyamura T
    Jpn J Infect Dis; 2001 Apr; 54(2):80-2. PubMed ID: 11427750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of cytopathogenic enteric viruses in Lombardy 5 years after the introduction of antipoliomyelitic vaccination with the Sabin vaccine].
    Galli MG
    Ann Sclavo; 1971; 13(3):362-9. PubMed ID: 4340984
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamilial transmission of a Sabin 1-related poliovirus in Shizuoka Prefecture, Japan.
    Sugieda M; Adachi S; Inayoshi M; Masuda T; Tsubota M; Mano H; Iwama M; Murakami Y; Yoshida H; Shimizu H
    Jpn J Infect Dis; 2006 Aug; 59(4):277-8. PubMed ID: 16936354
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.
    Osei-Kwasi M; Afari EA; Mimura K; Obeng-Ansah I; Ampofo WK; Nkrumah FK
    Bull World Health Organ; 1995; 73(1):41-6. PubMed ID: 7704924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Appearance of enterovirus in the Takatsumi district in Osaka after poliovirus vaccination. 2. Neutralizing antibodies for ECHO-4, ECHO-6 and various types of poliovirus in the inhabitants].
    Inami S
    Nihon Shonika Gakkai Zasshi; 1966 Jun; 70(6):554-60. PubMed ID: 4288853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.